Clinical Trials in Denmark / NCT06655012
Recruiting
Not applicable
Salmeterol Effect on Exercise Performance
NCT06655012 · tracked via the Priya Life Science Denmark tracker
Condition(s) studied
Healthy
Investigational drug(s) / intervention(s)
Salmeterol →Placebo
Salmeterol: Participants are administered 200 µg salmeterol (8 puffs) from a MDI device
Placebo: Participants are administered placebo (8 puffs) from a MDI device
Study summary
The purpose of the project is to investigate the muscle anabolic response to acute beta2-adrenergic stimulation in young healthy men and women.
Eligibility
Inclusion Criteria:
* Inclusion Criteria:
* Age 18-40
* Physically active \>5 hours a week
* Maximum oxygen uptake classified as high or very high
Exclusion Criteria:
* Active smoker currently or within the past 5 years
* Regular intake of medication deemed by the responsible study physician to affect the test parameters (hormonal contraception is accepted for women)
* Chronic or acute illness deemed by the responsible study physician to affect the test parameters
* Deviation from the study protocol
* Lean mass index \>21 kg/m²
* Pregnancy
* Smoker
* Blood donation during the past 3 months
Primary outcome measure(s)
- Power output during sprint testing — Through study completion, an average on 2 weeks
Power output measured in Watts during a sprint on a bike ergometer
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| August Krogh Building | Copenhagen | Denmark | Recruiting |
More University of Copenhagen trials in Denmark
Ayurvedic Diet in Myxedema
Recruiting
Other trials for the same condition
GastroFlow: Investigation of the Gastrointestinal Blood Flow in Patients With Postprandial Hypotension
Enrolling by invitation
Proteomic Analysis on Myopic Children Using Orthokeratology Lenses With Good or Poor Myopic Control
Active, not recruiting
Detection of Electrodermal Activity in Pain 1
Active, not recruiting
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06655012 on ClinicalTrials.gov ↗ ← All trials in Denmark